Amgen will be shifting towards a flexible workplace, allowing its 24,000 global employees to continue working from home. The drugmaker is looking forward to implementing a hybrid model that encourages onsite collaboration and enables employees to work remotely if they wish to.
More and more companies are coming forward with hybrid model implementations in the workplace. As studies continue to demonstrate, the future of work is no longer fully remote work but a hybrid structure that encourages collaboration and connection among employees.
Amgen Says Yes to Remote Work
One of the world’s largest biotechnology companies, Amgen, conducted a survey for its 5,000 employees located in Ventura County. The internal survey revealed that 80% of employees wish to continue working from home some days of the workweek.
The drugmaker stated that:
Our intent is to create a new, more flexible work environment that intentionally combines the benefits of remote and in-person working.
However, they are also pushing towards a remote model for financial reasons. The company shared that lower operating expenses have helped them preserve its bottom line. Amgen reported $5.9 billion in revenue in the first quarter of 2021; that’s 4% lower than in the same quarter in 2020.
According to Robert Bradway, Amgen’s CEO:
While our business continued to be impacted by the COVID-19 pandemic, particularly in the first two months of the quarter, we are encouraged by strong volume trends in many of our newer products and remain confident in the outlook for the full year.
And while the situation of the pandemic has made it complicated for the business, they’ve experienced the benefits of remote work: employees’ productivity has increased. Therefore, a couple of days ago, Amgen announced that implementing a hybrid model would work best for their financial interests as well as for their company’s employees.
